Nuvectis Pharma (NVCT) News Today $8.17 -0.11 (-1.33%) Closing price 04:00 PM EasternExtended Trading$8.20 +0.03 (+0.37%) As of 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVCT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Austin Wealth Management LLC Buys Shares of 40,250 Nuvectis Pharma, Inc. (NASDAQ:NVCT)July 11, 2025 | marketbeat.comIridian Asset Management LLC CT Acquires Shares of 253,972 Nuvectis Pharma, Inc. (NASDAQ:NVCT)July 9, 2025 | marketbeat.comNuvectis Pharma Announces Successful Completion of a Drug-Drug Interaction Study in Healthy Volunteers Supporting NXP900's Potential as a Combination Partner with Leading TherapiesJuly 8, 2025 | finance.yahoo.comNuvectis Pharma (NASDAQ:NVCT) Lowered to "Sell" Rating by Wall Street ZenJune 29, 2025 | marketbeat.comMarlio Charles Mosseri Buys 5,603 Shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT) StockJune 25, 2025 | insidertrades.comNuvectis Pharma, Inc. (NASDAQ:NVCT) Major Shareholder Buys $44,767.97 in StockJune 24, 2025 | marketbeat.comInsider Buying: Nuvectis Pharma, Inc. (NASDAQ:NVCT) Major Shareholder Acquires 5,399 Shares of StockJune 21, 2025 | insidertrades.comNuvectis Pharma (NASDAQ:NVCT) Stock Rating Upgraded by Wall Street ZenJune 21, 2025 | marketbeat.comMarlio Charles Mosseri Purchases 5,399 Shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT) StockJune 20, 2025 | marketbeat.comMarlio Charles Mosseri Purchases 28,043 Shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT) StockJune 20, 2025 | marketbeat.comInsiders of Nuvectis Pharma, Inc. (NASDAQ:NVCT) must be disappointed as stock fell 10% after recent purchasesJune 18, 2025 | finance.yahoo.comNuvectis Pharma: Still Interesting, But Still Too Risky To Jump InJune 18, 2025 | seekingalpha.comMillennium Management LLC Reduces Holdings in Nuvectis Pharma, Inc. (NASDAQ:NVCT)June 13, 2025 | marketbeat.comNuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor ConferenceMay 16, 2025 | globenewswire.comNuvectis Pharma, Inc. (NASDAQ:NVCT) Major Shareholder Marlio Charles Mosseri Buys 21,167 SharesMay 14, 2025 | insidertrades.comHC Wainwright Predicts Stronger Earnings for Nuvectis PharmaMay 11, 2025 | marketbeat.comQ2 EPS Estimates for Nuvectis Pharma Lifted by Roth CapitalMay 11, 2025 | marketbeat.comInsider Buying: Nuvectis Pharma, Inc. (NASDAQ:NVCT) Major Shareholder Purchases 2,650 Shares of StockMay 10, 2025 | insidertrades.comNuvectis Pharma (NASDAQ:NVCT) Is In A Good Position To Deliver On Growth PlansMay 9, 2025 | finance.yahoo.comNuvectis Pharma (NASDAQ:NVCT) Issues Earnings ResultsMay 8, 2025 | marketbeat.comNuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights | ...May 6, 2025 | gurufocus.comNuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business HighlightsMay 6, 2025 | gurufocus.comNuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business HighlightsMay 6, 2025 | globenewswire.comMarshall Wace LLP Acquires 81,757 Shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT)May 4, 2025 | marketbeat.comNuvectis Pharma (NASDAQ:NVCT) Earns "Buy" Rating from HC WainwrightMay 2, 2025 | marketbeat.comNuvectis Pharma, Inc. Announces Positive Phase 1a Data for NXP900 Demonstrating Robust Pharmacodynamic Responses and Acceptable Safety ProfileMay 1, 2025 | nasdaq.comNuvectis Pharma (NVCT) Projected to Post Earnings on TuesdayMay 1, 2025 | marketbeat.comNuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR MeetingApril 29, 2025 | globenewswire.comNuvectis Pharma (NASDAQ:NVCT) Trading 5.3% Higher - Here's What HappenedApril 27, 2025 | marketbeat.comMaxim Group Begins Coverage on Nuvectis Pharma (NASDAQ:NVCT)April 4, 2025 | marketbeat.comMaxim Group Initiates Coverage of Nuvectis Pharma (NVCT) with Buy RecommendationApril 3, 2025 | msn.comNuvectis Pharma initiated with a Buy at MaximApril 2, 2025 | markets.businessinsider.comNuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2025 American Association for Cancer Research MeetingMarch 26, 2025 | markets.businessinsider.comNuvectis Pharma, Inc. (NASDAQ:NVCT) Short Interest UpdateMarch 20, 2025 | marketbeat.comLaidlaw Begins Coverage on Nuvectis Pharma (NASDAQ:NVCT)March 18, 2025 | marketbeat.comLaidlaw & Co. Initiates Coverage of Nuvectis Pharma (NVCT) with Buy RecommendationMarch 18, 2025 | msn.comNuvectis Pharma initiated with a Buy at LaidlawMarch 17, 2025 | markets.businessinsider.comNuvectis Pharma to Participate in the 37th Annual Roth ConferenceMarch 14, 2025 | globenewswire.comNuvectis announces new publication of research study on NXP900, osimertinibMarch 4, 2025 | markets.businessinsider.comAnalysts Set Expectations for Nuvectis Pharma Q1 EarningsMarch 1, 2025 | marketbeat.comRoth Capital Forecasts Reduced Earnings for Nuvectis PharmaMarch 1, 2025 | marketbeat.comFY2028 EPS Forecast for Nuvectis Pharma Reduced by AnalystFebruary 28, 2025 | marketbeat.comMarket News Alert: Nuvectis Pharma Receives $18 Price Target and Buy Rating from Lucid Capital MarketsFebruary 27, 2025 | businesswire.comNuvectis Pharma price target lowered to $11 from $21 at H.C. WainwrightFebruary 25, 2025 | markets.businessinsider.comHC Wainwright Cuts Nuvectis Pharma (NASDAQ:NVCT) Price Target to $11.00February 25, 2025 | marketbeat.comNuvectis Pharma reports FY24 EPS ($1.11) vs. ($1.43) last yearFebruary 25, 2025 | markets.businessinsider.comNuvectis Pharma, Inc. Reports 2024 Financial Results and Business HighlightsFebruary 25, 2025 | finance.yahoo.comNuvectis Pharma (NVCT) to Release Earnings on TuesdayFebruary 25, 2025 | marketbeat.comNuvectis Pharma, Inc. (NASDAQ:NVCT) Major Shareholder Marlio Charles Mosseri Buys 240,000 SharesFebruary 12, 2025 | insidertrades.comNuvectis pharma investor acquires $1.2 million in stockFebruary 11, 2025 | msn.com Get Nuvectis Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for NVCT and its competitors with MarketBeat's FREE daily newsletter. Email Address NVCT Media Mentions By Week NVCT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVCT News Sentiment▼1.850.97▲Average Medical News Sentiment NVCT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVCT Articles This Week▼21▲NVCT Articles Average Week Get Nuvectis Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for NVCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies STOK News URGN News PHAT News RLAY News ABUS News TNGX News CDXC News DNTH News MGTX News UPB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVCT) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvectis Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvectis Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVCT Stock Alerts